IC
BIIB icon

Institutional Capital’s Biogen BIIB Stock Holding History

Institutional Capital’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-636,517
Closed -$257M – 48
2015
Q2 		$257M Sell
636,517
-23,380
-4% -$9.38M 1.8% 27
2015
Q1 		$279M Buy
+659,897
New +$260M 1.71% 25

Other funds holding BIIB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

Institutional Capital's BIIB Position: Q3 2015 in Review

Institutional Capital sold out of Biogen (BIIB) in Q3 2015, closing a stake of 636,517 shares — an estimated $257M sold.

Institutional Capital first reported a position in BIIB in Q1 2015 and held it in 2 quarters. The position peaked at $279M in Q1 2015. 923 funds tracked by Wall St. Rank hold BIIB as of Q3 2015.

  • Institutional Capital reported no remaining Biogen position as of Q3 2015 after selling out during the quarter.
  • Institutional Capital sold 636,517 Biogen shares in Q3 2015, an estimated $257M.
  • Institutional Capital first reported a position in Biogen in Q1 2015 and held it in 2 quarters.
  • Institutional Capital's Biogen position peaked at $279M in Q1 2015.
  • 923 funds tracked by Wall St. Rank held Biogen as of Q3 2015.

Based on Institutional Capital's 13F filing for Q3 2015, filed 12 Nov 2015.